SynapDx

What SynapDx does

SynapDx operates as a direct-to-consumer online marketplace selling pharmaceutical-grade human growth hormone (HGH) and GLP-1/Semaglutide medications to individual consumers globally. The product catalog spans multiple HGH brands including Genotropin, Zptropin, Spectros, Somatropin 191aa, Cinnatropin, and Geriostim Aqua in kit and pen formats, plus Ozempic 1 mg and Semaglutide 2 mg and 5 mg formulations, with unit prices ranging from approximately $110 to $550. Customers self-select and purchase through the synapdx.com storefront, with payment accepted via cryptocurrency (Bitcoin, Ethereum) and PayPal.

The platform differentiates on product authentication through an anti-counterfeit security system (holograms and unique verification codes checkable on manufacturer websites) and QR code integration with the Turkish Pharmacy Verification System for Genotropin products. SynapDx publishes third-party lab test results showing actual purity levels for select brands and operates dual fulfillment centers in the USA and Turkey, enabling 2-4 day domestic USA delivery versus 9-16 days internationally. Acquisition is driven primarily by content marketing (blog, FAQ, educational articles on HGH therapy) targeting fitness, anti-aging, recovery, and weight-management personas.

The business model is one-time-purchase e-commerce with no subscription tier, no enterprise channel, and no disclosed institutional investors or parent company. Firmographics metadata describes SynapDx as an early-stage laboratory services company developing blood-based diagnostic tests for the early detection of autism, founded in 2010 in Lexington, USA; this characterization conflicts with the current website operations and may reflect either a prior business model or outdated registry data, so the live operational description above is treated as authoritative.

Name

SynapDx

Legal name

SynapDx

Website

https://synapdx.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

SynapDx is a direct-to-consumer online marketplace selling pharmaceutical-grade human growth hormone (HGH) products and Semaglutide/GLP-1 medications to individual consumers worldwide, with dual fulfillment centers in the USA and Turkey.

Ownership category

akta.pro rank

Product category

Online Hormone Therapy Pharmacy

NAICS

Health and Personal Care Retailers (456)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

Keywords

• Online pharmacy
• HGH products
• Semaglutide medications
• Hormone therapy
• Weight loss injectables

Headquarters

HQ city

Lexington

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Others

Revenue model

1. Product Sales (HGH and Related Products): One-time purchase model for HGH kits, injectable pens, and Semaglutide products. Customers buy individual products at listed prices with discounts on sales items. Revenue generated from the markup between wholesale procurement and retail pricing to end consumers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

SynapDx is a direct-to-consumer online retailer of pharmaceutical-grade human growth hormone (HGH) injectables and Semaglutide/GLP-1 medications, sold under multiple brand labels including Genotropin, Zptropin, Spectros, Cinnatropin, Geriostim Aqua, and Somatropin 191aa, as well as Ozempic and Semaglutide 2 mg/5 mg. Products are procured from licensed manufacturers and Turkish pharmacies, fulfilled from USA and Turkey distribution points, and supported by an in-house anti-counterfeit verification system (holograms, unique codes, Turkish Pharmacy QR codes) and third-party lab-tested purity results.

Product overview

SynapDx operates as an online pharmacy marketplace specializing in pharmaceutical-grade hormone therapy and weight management medications. The product portfolio consists of two main categories: HGH (Human Growth Hormone) products including Spectros, Genotropin, Zptropin, Somatropin 191aa, Cinnatropin, and Geriostim Aqua in various dosages and formulations (both international and USA domestic variants); and GLP-1 medications including Ozempic (semaglutide 1 mg), Semaglutide 5 mg, and Semaglutide 2 mg for diabetes and obesity treatment. The company supplements its product sales with a lab testing verification service that validates product authenticity and purity. Products are sourced from certified facilities with anti-counterfeit security systems including holograms and unique verification codes.

Differentiator

Problem solved

Functional benefit

Products and services

• Spectros 280 IU (USA Domestic) Pharmaceutical-grade human growth hormone injectable kit marketed for muscle growth, fat reduction, and anti-aging; sold with USA domestic 2-4 day shipping.
• Genotropin 36 IU Pharma-grade human growth hormone pen device for treating growth hormone deficiency and associated conditions, integrated with the Turkish Pharmacy Verification System.
• Geriostim Aqua 100 IU Pen (USA Domestic) Aqua-based human growth hormone pen formulation for subcutaneous injection, fulfilled from the USA for faster domestic delivery.
• Cinnatropin 30 IU Human growth hormone product positioned for muscle development, fat metabolism, and recovery enhancement, sold as a lower-cost Chinese-brand alternative.
• Zptropin 160 IU Kit (USA Domestic) High-concentration HGH kit marketed for muscle gain and body composition improvement, fulfilled domestically in the USA for 2-4 day delivery.
• Zptropin 160 IU Kit International variant of the Zptropin 160 IU HGH kit for muscle gain, fat reduction, and anti-aging therapy, shipped from the Turkey fulfillment center.
• Somatropin 191aa (150 IU Kit) Pure recombinant human growth hormone (191 amino acid sequence) marketed for muscle growth and tissue repair, fulfilled from Turkey.
• Somatropin 191aa (150 IU Kit) (USA Domestic) USA-domestic variant of the pure 191aa HGH kit, positioned for muscle development and recovery with faster domestic delivery.
• Spectros 140 IU Kit Pharmaceutical-grade human growth hormone kit positioned for muscle growth, bone health, and metabolic support, fulfilled internationally from Turkey.
• Spectros 140 IU Kit (USA Domestic) USA-domestic variant of the Spectros 140 IU HGH kit for same-region delivery with faster transit times.
• Ozempic 1 mg (USA Domestic) Semaglutide injectable pen for type 2 diabetes management and weight loss; a GLP-1 receptor agonist that improves glycemic control and reduces cardiovascular risk.
• Semaglutide 5 mg GLP-1 receptor agonist medication for type 2 diabetes and obesity treatment, manufactured using Saccharomyces cerevisiae yeast and positioned for weight loss via appetite suppression and improved insulin sensitivity.
• Semaglutide 2 mg Lower-dose semaglutide formulation for type 2 diabetes control and weight management using a weekly subcutaneous injection protocol.
• HGH Lab Testing Verification Third-party laboratory testing service verifying HGH product authenticity, content accuracy, and purity levels for the brands retailed on the site.

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Hims & Hers Health: Public telehealth platform selling GLP-1 weight-loss treatments and men's health products direct-to-consumer online; comparable because it occupies the same direct-to-consumer online channel for semaglutide-tier medications and ancillary hormone/wellness products.
• Ro: Direct-to-consumer telehealth and pharmacy platform offering GLP-1 medications, hormone therapy, and men's/women's health treatments online; comparable as a regulated, brand-led online channel competing for the same semaglutide-seeking consumer.
• LifeMD: Public telehealth operator with an online pharmacy and direct-to-consumer marketing for weight management, hormone, and men's health products, including compounded semaglutide; comparable distribution model and customer acquisition channels.
• OptumRx (UnitedHealth Group pharmacy): Largest US mail-order pharmacy distributing branded and generic pharmaceuticals including HGH and semaglutide through a regulated channel; represents the legitimate end of the same distribution chain SynapDx is attempting to compete in.

Direct peers

• PureRawz: Online retailer of research-peptide and HGH products sold direct to US consumers without prescription; comparable product mix, pricing tiers, and DTC e-commerce model.
• Elijah Online Pharmacy / similar gray-market HGH storefronts: Independent online storefronts marketing pharma-grade HGH kits and semaglutide direct to US consumers with similar pricing, QR-based verification, and dual-country fulfillment; directly comparable operating model to SynapDx.
• PoloPharma: Online pharmacy storefront retailing pharma-grade HGH and peptide kits to international consumers with comparable brand mix and DTC positioning.
• Peptide Sciences: Long-running online retailer of HGH, peptides, and ancillary hormones marketed direct-to-consumer with lab-test claims; comparable catalogue, customer base, and verification messaging.
• Beligas International: Direct-to-consumer HGH/peptide brand selling internationally with branded kits and Western/Chinese brand tiers similar to SynapDx's Spectros and Zptropin lines.

Emerging players

• Legit Health / TRT clinics (e.g., Defy Medical): Online hormone-optimization clinics prescribing testosterone and HGH to qualified patients via telehealth; comparable end customer and treatment goal but operates through legitimate prescription pathways rather than direct OTC retail.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/SynapDxCorp
• LinkedInlinkedin.com/company/synapdx

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SynapDx